Research libraryMOLEKUL / SOURCE RECORD

Noofen in chronic cerebrovascular insufficiency with fatigue

O. V. Vorobieva; V. V. Rusaya · 2017 · S. S. Korsakov Journal of Neurology and Psychiatry, 117(11), pp. 31–36

Indexed 2026-11-12.

Human comparative studyRussian source · see review scopeSource linked

Reported findings and study design

Reported findings

Six-week comparison. The authors report random assignment to oral phenibut hydrochloride 500 mg twice daily plus standard care, or standard care alone. The main measure was the MFI-20 fatigue score.

Dose, route and schedule

Six-week comparison. The authors report random assignment to oral phenibut hydrochloride 500 mg twice daily plus standard care, or standard care alone. The main measure was the MFI-20 fatigue score.

Protocol source ↗ · Original source

Results · Original Russian-language source
MeasureResultComparison, timing and statistics
Fatigue scoreMFI-20 fell from 67.3±4.7 to 41.4±3.1 in the Noofen arm (within-arm p<0.001). Authors reported no change in usual care.
Participants with 30–50% lower fatigue scores25/33 (75.8%) with add-on Noofen versus 5/20 (25%) with usual care.

No placebo or masking is described. Chronic cerebral ischemia was required for inclusion. The trial measured fatigue in that population.

Source for these results ↗ · Reviewed 2026-11-12

For research and education. Consult a qualified clinician for medical advice.

Study limitations and source details

Study limitations

  • No placebo or masking is described. Chronic cerebral ischemia was required for inclusion. The trial measured fatigue in that population.

Source access

Six-week comparison. The authors report random assignment to oral phenibut hydrochloride 500 mg twice daily plus standard care, or standard care alone. The main measure was the MFI-20 fatigue score.

Source reviewed 2026-11-12.

Open source ↗

DOI: 10.17116/jnevro201711711131-36

Citation and original source

Original source: O. V. Vorobieva; V. V. Rusaya. Noofen in chronic cerebrovascular insufficiency with fatigue S. S. Korsakov Journal of Neurology and Psychiatry, 117(11), pp. 31–36 2017.

Molekul research summary: https://molekul.io/research/phenibut-vorobieva-fatigue-2017. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards